| 
    ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
  | |
  | Phenotypic Information (metabolism pathway, cancer, disease, phenome)  | 
  | |
  | |
  | Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG  | 
  | |
  | 
| Gene Summary for MTHFD2L | 
| Top | 
| Phenotypic Information for MTHFD2L(metabolism pathway, cancer, disease, phenome) | 
| Cancer | CGAP: MTHFD2L | 
| Familial Cancer Database: MTHFD2L | |
| * This gene is included in those cancer gene databases. | 
  | 
  | 
  | 
  | 
  | 
  | 
  | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Oncogene 1  | Significant driver gene in  | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|  cf) number; DB name  1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/  | 
| KEGG_GLYOXYLATE_AND_DICARBOXYLATE_METABOLISM | |
| Mutations for MTHFD2L | 
| * Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. | 
| - Statistics for Tissue and Mutation type | Top | 
![]()  | 
| - For Inter-chromosomal Variations | 
| There's no inter-chromosomal structural variation. | 
| - For Intra-chromosomal Variations | 
| * Intra-chromosomal variantions includes 'intrachromosomal amplicon to amplicon', 'intrachromosomal amplicon to non-amplified dna', 'intrachromosomal deletion', 'intrachromosomal fold-back inversion', 'intrachromosomal inversion', 'intrachromosomal tandem duplication', 'Intrachromosomal unknown type', 'intrachromosomal with inverted orientation', 'intrachromosomal with non-inverted orientation'. | 
![]()  | 
| Sample | Symbol_a | Chr_a | Start_a | End_a | Symbol_b | Chr_b | Start_b | End_b | 
| ovary | MTHFD2L | chr4 | 75044856 | 75044876 | chr4 | 71997962 | 71997982 | |
| ovary | MTHFD2L | chr4 | 75071458 | 75071478 | chr4 | 67409359 | 67409379 | 
| cf) Tissue number; Tissue name (1;Breast, 2;Central_nervous_system, 3;Haematopoietic_and_lymphoid_tissue, 4;Large_intestine, 5;Liver, 6;Lung, 7;Ovary, 8;Pancreas, 9;Prostate, 10;Skin, 11;Soft_tissue, 12;Upper_aerodigestive_tract) | 
| * From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows MTHFD2L related fusion information. | 
| ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | 
| BU155734 | LGALS1 | 1 | 507 | 22 | 38071663 | 38075809 | MTHFD2L | 493 | 515 | 4 | 75023137 | 75023161 | |
| AK023167 | ZDHHC20 | 3 | 260 | 13 | 22033193 | 22033450 | MTHFD2L | 261 | 2138 | 4 | 75065511 | 75168812 | |
| AX794778 | ZDHHC20 | 3 | 260 | 13 | 22033193 | 22033450 | MTHFD2L | 261 | 2138 | 4 | 75065511 | 75168812 | |
| Top | 
| Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
| Total # sample | 2 |   | 1 |   |   |   | 5 |   | 2 |   | 3 |   |   |   |   |   |   | |||
| GAIN (# sample) | 2 |   | 1 |   |   |   |   |   |   |   | 2 |   |   |   |   |   |   | |||
| LOSS (# sample) |   |   |   |   |   |   | 5 |   | 2 |   | 1 |   |   |   |   |   |   | 
| cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) | 
| Top | 
   | 
![]()  | 
| Top | 
| Stat. for Non-Synonymous SNVs  (# total SNVs=20)  | (# total SNVs=4)  | 
![]()  | ![]()  | 
(# total SNVs=3)  | (# total SNVs=0)  | 
![]()  | 
| Top | 
| * When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. | 
| GRCh37 position | Mutation(aa) | Unique sampleID count | 
| chr4:75167509-75167509 | p.I287fs*>3 | 3 | 
| chr4:75040332-75040332 | p.S27G | 2 | 
| chr4:75065603-75065603 | p.D124N | 2 | 
| chr4:75091075-75091075 | p.H199Y | 1 | 
| chr4:75040299-75040299 | p.W16R | 1 | 
| chr4:75065528-75065528 | p.T99A | 1 | 
| chr4:75091079-75091079 | p.T200M | 1 | 
| chr4:75040300-75040300 | p.W16L | 1 | 
| chr4:75167517-75167517 | p.I287I | 1 | 
| chr4:75065537-75065537 | p.N102D | 1 | 
| Top | 
   | 
![]()  | 
| Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 
| # sample |   | 1 |   | 6 | 1 |   |   |   |   |   |   | 1 | 1 | 1 |   |   | 5 | 2 | 1 | 5 | 
| # mutation |   | 1 |   | 5 | 1 |   |   |   |   |   |   | 1 | 2 | 1 |   |   | 5 | 2 | 1 | 5 | 
| nonsynonymous SNV |   |   |   | 5 | 1 |   |   |   |   |   |   | 1 | 2 | 1 |   |   | 4 | 2 | 1 | 3 | 
| synonymous SNV |   | 1 |   |   |   |   |   |   |   |   |   |   |   |   |   |   | 1 |   |   | 2 | 
| cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) | 
| Top | 
| * We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. | 
| Genomic Position | Mutation(aa) | Unique sampleID count | 
| chr4:75040332 | p.S85G | 2 | 
| chr4:75167517 | p.W74L | 1 | 
| chr4:75040299 | p.G289D | 1 | 
| chr4:75065631 | p.G78G | 1 | 
| chr4:75040300 | p.V297V | 1 | 
| chr4:75065637 | p.P321S | 1 | 
| chr4:75040313 | p.S85I | 1 | 
| chr4:75091075 | p.L334F | 1 | 
| chr4:75091079 | p.G142S | 1 | 
| chr4:75040333 | p.I345I | 1 | 
| * Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. | 
![]()  | 
| cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] | 
| Top | 
| Gene Expression for MTHFD2L | 
| * CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. | 
![]()  | 
| * Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR))  | 
![]()  | 
| Top | 
| * This plots show the correlation between CNV and gene expression. | 
![]()  | 
  | 
![]()  | 
  | 
| Top | 
| Gene-Gene Network Information | 
| * Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene  | 
![]()  | 
  | 
| C11orf71,COA5,FAM200B,GRSF1,DANCR,LOC100303728,LOC147727, LOC202781,LOC400027,LOC400752,LOC401588,MRPL1,MTHFD2L,RCHY1, RUFY3,SDAD1,SNHG10,TCTE3,THAP6,THAP9,UTP3  | ACTR6,AP1AR,VCPKMT,C5orf28,CAAP1,CLDN12,CSNK1A1, EEF1E1,KIAA0895,LZTFL1,LAMTOR3,MTHFD2L,NUP35,NUPL2, ORC4,POT1,PRSS16,SRSF6,SVIP,TMEM161B,ZBED5  | 
![]()  | 
  | 
| ATP5L,C14orf142,COMMD8,COX18,DCK,DANCR,MTHFD2L, MYEOV2,NDUFB1,NUDCD2,NUP54,ORC4,PACRGL,PHF5A, RCHY1,SDHD,SNRPG,TIMM8B,TMEM126B,TOMM22,UQCR10  | BRIX1,DTD2,KATNBL1,C5orf28,TRAPPC13,CCDC58,TRMT13, MRPL1,MRPL32,MRPL50,MTERF3,MTHFD2L,NUPL2,OTUD6B, PAK1IP1,PRMT3,PTRH2,RCN2,TRMT10C,TAF9,TRUB1  | 
| * Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene  | 
| Top | 
| Top | 
| Pharmacological Information for MTHFD2L | 
| There's no related Drug. | 
| Top | 
| Cross referenced IDs for MTHFD2L | 
| * We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section | 
| 
             Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @  |